Business

Merck Presents Results of Study

Merck said a study of its once-daily formulation of ISENTRESS (raltegravir) for the treatment of adults with HIV-1 infection found that after 48 weeks of treatment, 1200 mg raltegravir was statistically non-inferior to the marketed formulation approved dose of ISENTRESS 400 mg twice-daily. Furthermore, the study showed comparable rates of[Read More…]

by July 22, 2016

Cintas Rises to Record High

Cintas shares rose to a new high on Wednesday after the provider of corporate identity uniforms and other items said late Tuesday that fiscal Q4 sales rose 11.3% to $1.27 billion from the year-ago level and were above the CapIQ mean for $1.25 billion. CTAS was up 12% at $108.79,[Read More…]

by July 20, 2016

Zafgen Shares Hit New Low

Zafgen shares fell to a new low on Wednesday after the company said it has concluded a review of its assets and clinical programs, taking into account feedback from regulatory authorities, and is refocusing on development of a differentiated second-generation MetAP2 inhibitor in severe and complicated obesity. ZFGN was down[Read More…]

by July 20, 2016

Orbital ATK Says FLY SpA to Supply It With Parts Under $68 Mln Long-Term Deal

Orbital ATK  shares were higher 1% on Monday after the aerospace and defense technologies provider said it has struck a $68 million long-term deal for Italy’s FLY SpA to supply it with various components. FLY will provide metallic case components through 2026 for the Rolls-Royce Trent XWB-84k engine that powers[Read More…]

by July 18, 2016

Sempra Energy Gets DOE OK to Export Gas From Cameron LNG Terminal to Non-FTA Countries

Sempra Energy shares were just higher Monday after the energy services holding firm said its Cameron LNG project was granted Department of Energy authorization to export an extra 1.41 billion cubic feet of gas per day to countries that do not have a free-trade agreement with the U.S. With this[Read More…]

by July 18, 2016